(Total Views: 1174)
Posted On: 10/05/2020 12:10:51 AM
Post# of 156648
President had stakes in Regeneron and Gilead, makers of antibody cocktail, Remdesivir
Kelly Tyko, USA TODAY 1 day ago
USA TODAY logoTrump COVID-19 treatment: President had stakes in Regeneron and Gilead, makers of antibody cocktail, Remdesivir
President Donald Trump previously reported he earned capital gains from Regeneron Pharmaceuticals and Gilead Sciences Inc., the manufacturers of two of the medicines he's taken as part of his COVID-19 treatment plan.
President Donald Trump previously reported he earned capital gains from Regeneron Pharmaceuticals and Gilead Sciences Inc., the manufacturers of two of the medicines he's taken as part of his COVID-19 treatment plan.
According to a 2017 financial disclosure form filed with the U.S. Office of Government Ethics in June 2017, Trump had a capital gain of $50,001 to $100,000 for Regeneron Pharmaceuticals and $100,001 to $1 million for Gilead Sciences Inc. The form notes the information was of April 15, 2017.
Trump’s subsequent disclosure forms, including his 2020 form signed July 31, did not list Regeneron or Gilead.
Trump received a single 8-gram dose of Regeneron's polyclonal antibody cocktail as a precautionary measure, according to his physician Sean Conley. The antibody cocktail is in four late-stage clinical trials, and its safety and efficacy have not been fully evaluated by any regulatory authority, the company said on its webpage.
((APOLOGIES if posted already. I just saw this on the other board.))
https://www.usatoday.com/story/money/2020/10/...610111001/
https://www.msn.com/en-us/news/us/trump-covid...uxbndlbing
Kelly Tyko, USA TODAY 1 day ago
USA TODAY logoTrump COVID-19 treatment: President had stakes in Regeneron and Gilead, makers of antibody cocktail, Remdesivir
President Donald Trump previously reported he earned capital gains from Regeneron Pharmaceuticals and Gilead Sciences Inc., the manufacturers of two of the medicines he's taken as part of his COVID-19 treatment plan.
President Donald Trump previously reported he earned capital gains from Regeneron Pharmaceuticals and Gilead Sciences Inc., the manufacturers of two of the medicines he's taken as part of his COVID-19 treatment plan.
According to a 2017 financial disclosure form filed with the U.S. Office of Government Ethics in June 2017, Trump had a capital gain of $50,001 to $100,000 for Regeneron Pharmaceuticals and $100,001 to $1 million for Gilead Sciences Inc. The form notes the information was of April 15, 2017.
Trump’s subsequent disclosure forms, including his 2020 form signed July 31, did not list Regeneron or Gilead.
Trump received a single 8-gram dose of Regeneron's polyclonal antibody cocktail as a precautionary measure, according to his physician Sean Conley. The antibody cocktail is in four late-stage clinical trials, and its safety and efficacy have not been fully evaluated by any regulatory authority, the company said on its webpage.
((APOLOGIES if posted already. I just saw this on the other board.))
https://www.usatoday.com/story/money/2020/10/...610111001/
https://www.msn.com/en-us/news/us/trump-covid...uxbndlbing
(0)
(0)
